While pivotal research on therapies for neovascular age-related macular degeneration (nAMD) and geographic atrophy (GA) ...

Retinitis pigmentosa retinal degeneration is caused by a family of hereditary mutations in nearly 100 genes that slowly lead to blindness over years or decades. One of those genes encodes the enzyme ...

"Pigment Epithelial Detachment - Market Insight, Epidemiology and Market Forecast"Retinal pigment epithelium market is poised for notable growth, being fueled by several factors, including an aging ...

Retinal disorders can significantly impact vision and if left untreated can lead to serious and sometimes permanent vision impairment and blindness. Early detection and treatment are crucial for ...

The hits just keep on coming for Regeneron’s Eylea franchise. Wednesday, the FDA extended its target action dates for two applications to expand the use of Eylea’s high-dose formulation. The U.S.

In this episode, guest John Barbieri, MD, MBA, discusses the FDA’s 2023 proposed changes to the iPledge system and the impacts of clinical trials and treatments on patients with hormonal acne. In this ...